Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pucotenlimab + LDRT + Chemotherapy in Advanced Pancreatic Cancer
NCT07312422Phase 2Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Sep 2025
- Primary completion
- Apr 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pucotenlimab in pancreatic cancer (PC), sponsored by Zhejiang Provincial People's Hospital. Started Sep 2025; status: recruiting.
02
Drugs
pucotenlimab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07312422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07312422.